Bioelectric medicine has different treatment therapy that is based on electrical pulse instead of drug trigger therapy. Bioelectric medicine develops nerve stimulating and sensors activation technologies to regulate biological functions and treat diseases by combining bioengineering, neuroscience, molecular medicines, electronics, and computing. These technologies may change the future of therapies for wide range of diseases. Bioelectric medicine acts through targeted mechanism of action to treat diseases.
The global bioelectric medicine market size was valued at US$ 12.3 billion in 2017, and is expected to witness a CAGR of 7.2% over the forecast period (2019–2026).

Get The Sample Report Here At: https://www.coherentmarketinsights.com/insight/request-sample/1757

Increasing Investment in Research & Development and Regulatory Approvals for Bioelectric Medicine Is Expected to Drive Growth of Global Bioelectric Medicine Market
Increasing approvals for bioelectric medicine products with better regulatory management by the regulatory authorities is expected to drive the global bioelectric medicine market growth during the forecast period. In March 2014, Cancer-Code Corporation (C3) announced issuance of patent which entitles: Method and System for Processing Cancer Cell Electrical Signals for Medical Therapy, which covers an innovative approach to eradicate cancer in humans and animals.

Furthermore, increasing products approvals is expected to inhibit the growth of the market. For instance, in 2014, the U.S. FDA approved Inspire Medical Systems’ Sleep Apnea Treatment to treat sleep apnea by implanting a device that stimulates air way muscles. Furthermore, in April 2017, U.S.FDA approved a device called GammaCore launched by ElectroCore that transmits a mild electrical simulation to the vagus nerve through the skin for Migraine.

Increasing investment in development of advanced bioelectric medicines is a major factor driving growth of global bioelectric medicine market. For instance, in 2016, Medtronic Plc, a bioelectric medicine manufacturer, invested around US$ 2,224 million in the overall research and development of advanced products in bioelectric medicine

Global Bioelectric Medicine Market- Restraints
High cost attached to treatment of Parkinson’s disease may hamper growth of the global bioelectric medicine market. For instance, according to Parkinson Foundation 2018, the average cost for medications of Parkinson’s disease is US$ 2,500 and therapeutic surgery cost up to US$100,000 per person in the U.S.

Global Bioelectric Medicine Market- Regional Insights
On the basis of region, the global bioelectric medicine market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global bioelectric medicine market during the forecast period, owing to high presence of key industry players in the region including Electrocore, St. Jude Medical, and Medtronic Plc. These players are increasingly focusing on development of bioelectric medicine product. For instance, Electro Core, a U.S.-based company is working on a device to treat headaches related to migraines by stimulating vagus nerve on the neck with electrical impulses.

Asia pacific is expected to witness a rapid growth in the global bioelectric medicine market. The market in Asia Pacific is expected to gain momentum during the forecast period, owing to increasing prevalence of chronic diseases such as diabetes and hearing loss, due to rapidly increasing geriatric population in the region. For instance, according to International Diabetes Federation, in China, there were over 114,394,800 cases of diabetes in 2017. Moreover, according World Health Organization  2013, around 27.8 million Chinese people suffer from loss of hearing and 11% of people aged 60 years and above have hearing loss in China.Global Bioelectric

To Get Instant Access, Purchse Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/1757


Medicine Market- Competitive Landscape
Key players operating in the global bioelectric medicine market include GlaxoSmithKline, Medtronic Plc., Boston Scientific Corporation, Liva Nova Plc, Electrocore, Nevro, and St. Jude Medical.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: [email protected]